150 related articles for article (PubMed ID: 28633424)
1. From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.
Ramaiahgari SC; Waidyanatha S; Dixon D; DeVito MJ; Paules RS; Ferguson SS
Toxicol Sci; 2017 Sep; 159(1):124-136. PubMed ID: 28633424
[TBL] [Abstract][Full Text] [Related]
2. Development of a human liver microphysiological coculture system for higher throughput chemical safety assessment.
Ip BC; Madnick SJ; Zheng S; van Tongeren TCA; Hall SJ; Li H; Martin S; Spriggs S; Carmichael P; Chen W; Ames D; Breitweiser LA; Pence HE; Bowling AJ; Johnson KJ; Cubberley R; Morgan JR; Boekelheide K
Toxicol Sci; 2024 May; 199(2):227-245. PubMed ID: 38335931
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.
Bell CC; Dankers ACA; Lauschke VM; Sison-Young R; Jenkins R; Rowe C; Goldring CE; Park K; Regan SL; Walker T; Schofield C; Baze A; Foster AJ; Williams DP; van de Ven AWM; Jacobs F; Houdt JV; Lähteenmäki T; Snoeys J; Juhila S; Richert L; Ingelman-Sundberg M
Toxicol Sci; 2018 Apr; 162(2):655-666. PubMed ID: 29329425
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing.
Seo JE; Le Y; Revollo J; Miranda-Colon J; Xu H; McKinzie P; Mei N; Chen T; Heflich RH; Zhou T; Robison T; Bonzo JA; Guo X
Arch Toxicol; 2024 Jun; 98(6):1919-1935. PubMed ID: 38584193
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Human Long-Term Liver Models for Clearance Prediction of Slowly Metabolized Compounds.
Preiss LC; Georgi K; Lauschke VM; Petersson C
Drug Metab Dispos; 2024 May; 52(6):539-547. PubMed ID: 38604730
[TBL] [Abstract][Full Text] [Related]
6. A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction.
Sun B; Liang Z; Wang Y; Yu Y; Zhou X; Geng X; Li B
Toxicology; 2024 May; 505():153829. PubMed ID: 38740170
[TBL] [Abstract][Full Text] [Related]
7. Hepatic spheroid-on-a-chip: Fabrication and characterization of a spheroid-based
AlShmmari SK; Fardous RS; Shinwari Z; Cialla-May D; Popp J; Ramadan Q; Zourob M
Biomicrofluidics; 2024 May; 18(3):034105. PubMed ID: 38817733
[TBL] [Abstract][Full Text] [Related]
8. Suitability of human HepaRG cells and liver spheroids as in vitro model to investigate the bioactivation of the organothiophosphate pesticide parathion.
Horn G; Worek F
Toxicol In Vitro; 2024 May; 97():105811. PubMed ID: 38521251
[TBL] [Abstract][Full Text] [Related]
9. In Situ Self-Assembling Liver Spheroids with Synthetic Nanoscaffolds for Preclinical Drug Screening Applications.
Wu L; Vllasaliu D; Cui Q; Raimi-Abraham BT
ACS Appl Mater Interfaces; 2024 May; 16(20):25610-25621. PubMed ID: 38741479
[TBL] [Abstract][Full Text] [Related]
10. Application of HepaRG cells for genotoxicity assessment: a review.
Guo X; Xu H; Seo JE
J Environ Sci Health C Toxicol Carcinog; 2024 Apr; ():1-24. PubMed ID: 38566478
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic, Proteomic, and Functional Long-Term Characterization of Multicellular Three-Dimensional Human Liver Microtissues.
Messner S; Fredriksson L; Lauschke VM; Roessger K; Escher C; Bober M; Kelm JM; Ingelman-Sundberg M; Moritz W
Appl In Vitro Toxicol; 2018 Mar; 4(1):1-12. PubMed ID: 32953943
[TBL] [Abstract][Full Text] [Related]
12. Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.
Ramaiahgari SC; Waidyanatha S; Dixon D; DeVito MJ; Paules RS; Ferguson SS
Toxicol Sci; 2017 Nov; 160(1):189-190. PubMed ID: 29077947
[No Abstract] [Full Text] [Related]
13. A liver-specific gene expression panel predicts the differentiation status of in vitro hepatocyte models.
Kim DS; Ryu JW; Son MY; Oh JH; Chung KS; Lee S; Lee JJ; Ahn JH; Min JS; Ahn J; Kang HM; Kim J; Jung CR; Kim NS; Cho HS
Hepatology; 2017 Nov; 66(5):1662-1674. PubMed ID: 28640507
[TBL] [Abstract][Full Text] [Related]
14. 3D in vitro models of liver fibrosis.
van Grunsven LA
Adv Drug Deliv Rev; 2017 Nov; 121():133-146. PubMed ID: 28697953
[TBL] [Abstract][Full Text] [Related]
15. Bioprinting Perfusion-Enabled Liver Equivalents for Advanced Organ-on-a-Chip Applications.
Grix T; Ruppelt A; Thomas A; Amler AK; Noichl BP; Lauster R; Kloke L
Genes (Basel); 2018 Mar; 9(4):. PubMed ID: 29565814
[TBL] [Abstract][Full Text] [Related]
16. Preliminary Evaluation of Three-Dimensional Primary Human Hepatocyte Culture System for Assay of Drug-Metabolizing Enzyme-Inducing Potential.
Arakawa H; Kamioka H; Jomura T; Koyama S; Idota Y; Yano K; Kojima H; Ogihara T
Biol Pharm Bull; 2017; 40(7):967-974. PubMed ID: 28674261
[TBL] [Abstract][Full Text] [Related]
17. An Intuitive Approach for Predicting Potential Human Health Risk with the Tox21 10k Library.
Sipes NS; Wambaugh JF; Pearce R; Auerbach SS; Wetmore BA; Hsieh JH; Shapiro AJ; Svoboda D; DeVito MJ; Ferguson SS
Environ Sci Technol; 2017 Sep; 51(18):10786-10796. PubMed ID: 28809115
[TBL] [Abstract][Full Text] [Related]
18. Organotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis.
Ramaiahgari SC; Ferguson SS
Methods Mol Biol; 2019; 1981():313-323. PubMed ID: 31016663
[TBL] [Abstract][Full Text] [Related]
19. Evaluating Sufficient Similarity of Botanical Dietary Supplements: Combining Chemical and In Vitro Biological Data.
Ryan KR; Huang MC; Ferguson SS; Waidyanatha S; Ramaiahgari S; Rice JR; Dunlap PE; Auerbach SS; Mutlu E; Cristy T; Peirfelice J; DeVito MJ; Smith-Roe SL; Rider CV
Toxicol Sci; 2019 Dec; 172(2):316-329. PubMed ID: 31504990
[TBL] [Abstract][Full Text] [Related]
20. Novel Strategy to Assess the Neurotoxicity of Organic Solvents Such as Glycol Ethers: Protocol for Combining In Vitro and In Silico Methods With Human-Controlled Exposure Experiments.
Hopf NB; Suter-Dick L; Huwyler J; Borgatta M; Hegg L; Pamies D; Paschoud H; Puligilla RD; Reale E; Werner S; Zurich MG
JMIR Res Protoc; 2024 Jan; 13():e50300. PubMed ID: 38236630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
